30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 30 of 30 clinical reviews.
Is it safe to take Praluent (alirocumab) with acetaminophen? A clinical review of pharmacokinetic and pharmacodynamic data, hepatic considerations, monitoring recommendations, and dose guidance.
Is it safe to take Praluent (alirocumab) with apixaban (Eliquis)? A detailed clinical review of pharmacokinetic and pharmacodynamic data, monitoring protocols, and prescribing considerations.
Board-reviewed guide to the alirocumab and atorvastatin drug interaction, covering mechanism, safety data from ODYSSEY trials, monitoring needs, dose adjustments, and patient counseling.
Clinical review of the interaction between alirocumab (Praluent) and benzodiazepines, covering pharmacokinetic and pharmacodynamic mechanisms, safety data, monitoring recommendations, and dose-adjustment guidance.
Can you take Praluent with estradiol HRT? A clinician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction profile, cardiovascular risk considerations, monitoring protocols, and dose-adjustment guidance for alirocumab combined with estrogen therapy.
Board-reviewed analysis of whether alirocumab (Praluent) and finasteride can be taken together, covering CYP metabolism, pharmacodynamic overlap, lipid effects, and monitoring recommendations.
A clinician-level review of the Praluent (alirocumab) and opioid interaction covering mechanism, severity, monitoring, dose adjustment, and patient counseling for oxycodone, hydrocodone, and tramadol.
Board-reviewed analysis of the drug interaction between alirocumab (Praluent) and proton pump inhibitors like omeprazole and pantoprazole. Covers pharmacokinetic mechanism, clinical data, and monitoring guidance.
Clinical review of the drug interaction between alirocumab (Praluent) and progesterone hormone replacement therapy, including pharmacokinetic analysis, lipid effects, monitoring recommendations, and patient counseling.
Clinical analysis of taking Praluent (alirocumab) with SNRIs like venlafaxine or duloxetine. Covers pharmacokinetic pathways, safety data, monitoring, and physician guidance.
Clinical guide to combining alirocumab (Praluent) with testosterone replacement therapy. Covers mechanism, severity, lipid monitoring, dose adjustment, and patient counseling.
A physician-reviewed guide to the alirocumab and bupropion drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling points.
A physician-reviewed guide to the alirocumab (Praluent) and clopidogrel drug interaction, covering mechanism, safety evidence, monitoring, and patient counseling.
A detailed clinical review of the alirocumab (Praluent) and diphenhydramine drug interaction: mechanism, risk level, monitoring parameters, and patient counseling points backed by primary literature.
Board-reviewed analysis of the alirocumab (Praluent) and gabapentin drug interaction, covering CYP450 pathways, renal clearance, pharmacodynamic overlap, and monitoring guidance.
A full clinical review of the alirocumab (Praluent) and hormonal contraceptives interaction, covering mechanism, safety data, monitoring, and patient counseling for women managing high cholesterol while on birth control.
A clinical deep-dive into the alirocumab (Praluent) and levothyroxine drug interaction: mechanism, severity, monitoring parameters, dose-adjustment strategy, and patient counseling points backed by FDA labeling and primary literature.
Is it safe to take Praluent (alirocumab) with metformin? A clinical review of drug interaction data, pharmacokinetics, monitoring recommendations, and real-world evidence for this common combination.
A clinical deep-dive into the alirocumab (Praluent) and NSAID interaction, covering pharmacokinetic and pharmacodynamic mechanisms, renal and GI risk, monitoring strategies, and patient counseling guidance.
A clinical deep-dive into the alirocumab-prednisone drug interaction: mechanism, LDL monitoring, glucose and cardiovascular risk management, and patient counseling points backed by primary literature.
A detailed clinical review of the alirocumab (Praluent) and pregabalin drug interaction, covering mechanism, pharmacokinetics, severity classification, monitoring recommendations, and patient counseling guidance.
A clinician-reviewed guide to the alirocumab (Praluent) and rivaroxaban drug interaction: mechanism, safety evidence, monitoring parameters, and patient counseling points.
Can you take Praluent (alirocumab) with rosuvastatin? A clinician-grade review of the pharmacokinetic data, clinical trial evidence, monitoring protocols, and dose-adjustment guidance for this common PCSK9 inhibitor-statin combination.
Is it safe to take alirocumab (Praluent) with sildenafil? A clinician-reviewed guide covering pharmacokinetics, cardiovascular overlap, monitoring, and dose considerations.
A clinician-level guide to the alirocumab (Praluent) and simvastatin drug interaction: mechanism, safety evidence, monitoring requirements, and dose guidance with primary literature citations.
A physician-reviewed guide to the alirocumab and SSRI interaction, covering mechanism, safety data, monitoring, and patient counseling for sertraline and escitalopram coadministration.
Alirocumab (Praluent) and tadalafil (Cialis) have no known pharmacokinetic interaction. Learn about their separate metabolic pathways, cardiovascular overlap, monitoring recommendations, and clinical evidence.
Clinical analysis of the alirocumab (Praluent) and trazodone drug interaction, including mechanism, severity, monitoring parameters, and dose adjustment guidance.
Can you take Praluent (alirocumab) with warfarin? Review the pharmacokinetic and pharmacodynamic evidence, monitoring protocols, and clinical recommendations for this drug combination.
Clinical review of alirocumab (Praluent) and zolpidem drug interaction risk, covering pharmacokinetic mechanisms, safety data, monitoring recommendations, and patient counseling.